Sean Aylmer

I'm Sean Aylmer.

Singapore-based Altia Investments, A-L-T-E-A, Altia Investments, has spent years building and investing in life sciences infrastructure across Asia.

Now, it's making a major bet on Brisbane with the launch of the new life science incubator at QIMR Berghofer.

Brisbane is fast becoming a healthcare and biotech hub for Australia in medical and pharmaceutical products.

Growth in the city has occurred seven times faster than the rest of the country.

Fear and Greed is working with the Brisbane Economic Development Agency to explore exactly why global companies are choosing to invest in Brisbane.

John Ratcliffe is CEO of Altair Investments.

He spends his time sometimes in Queensland, sometimes in Singapore.

Coming to me from Singapore this morning, John, welcome to Fear and Greed Q&A.

Thanks very much.

John, tell me about the Life Science Incubator.

What's the vision behind it?

So QIMR, we must say Queensland Institute of Medical Research, just for those who don't know the acronym.

When I started as a reporter, healthcare was a government thing.

It was costly.

It wasn't an innovative space.

I think now, and when I first started, John, admittedly, it was 25 years ago, right?

So now, though, it is probably one of the more exciting spaces around simply because it is so innovative and

I suppose it's a function of people like yourself investing in it.

Why is there so much global capital pushing towards life sciences more broadly at the moment?